Interesting article

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

Taurus

Paul Revere of Medicine
20+ Year Member
Joined
Jul 27, 2004
Messages
3,220
Reaction score
671
http://www.businessweek.com/magazin...62.htm?chan=top+news_top+news+index_top+story

The stir over stents has jolted a whole industry that took shape in the 1990s to cash in on the device's popularity. Boston Scientific (BSX ) and Johnson & Johnson (JNJ ), both of which make drug-coated stents and for which Sharma has performed many clinical trials, have slipped badly. With stent procedures down 13% nationally this year, Boston Scientific's stock is off 17%, and the company is expected to announce layoffs; J&J has said it will lay off more than 3,400 people, including many in its stent business. JPMorgan Chase (JPM ) estimates that sales of drug-coated stents will drop 23% in 2007, to $4.1 billion.
 
http://www.businessweek.com/magazin...62.htm?chan=top+news_top+news+index_top+story

The stir over stents has jolted a whole industry that took shape in the 1990s to cash in on the device's popularity. Boston Scientific (BSX ) and Johnson & Johnson (JNJ ), both of which make drug-coated stents and for which Sharma has performed many clinical trials, have slipped badly. With stent procedures down 13% nationally this year, Boston Scientific's stock is off 17%, and the company is expected to announce layoffs; J&J has said it will lay off more than 3,400 people, including many in its stent business. JPMorgan Chase (JPM ) estimates that sales of drug-coated stents will drop 23% in 2007, to $4.1 billion.


I have seen him in action at Mount Sinai....that Sharma dude is hard core. He is really an aggressive Interventional cardiologist....and is very good at what he does.
 
Terrific article...thank you for posting it.
 
Top